PDCD1 and neoplasm: More importantly, immune cells (CD8+ infiltrating lymphocytes; CD4+ TILS; macrophages; NK cells) are abundant in MSI-H/dMMR tumors and cell surface inhibitory checkpoint molecules of lymphocytes and tumor cells (PD-1, PD-L1, respectively) are increased correspondingly (17, 18) (Figure 2).